Table 2.
Age group | Men |
Women |
Total |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Population | TIA | Prevalenceb | 95% CIb | Population | TIA | Prevalenceb | 95% CIb | Prevalenceb | 95% CIb | |
0–24 | 83,953 | 0 | 0 | 0 | 76,429 | 0 | 0 | 0 | 0.0 | 0 |
25–34 | 45,020 | 3 | 3.0 | 0.8–11.8 | 46,415 | 3 | 2.2 | 0.3–14.8 | 2.6 | 0.8–8.1 |
35–44 | 50,759 | 11 | 14.4 | 6.9–30.1 | 48,823 | 19 | 24.5 | 13.5–44.5 | 19.3 | 11.2–33.3 |
45–54 | 46,879 | 55 | 112.9 | 74.7–170.4 | 46,884 | 82 | 144.8 | 93.5–224.1 | 128.5 | 93.1–177.4 |
55–64 | 39,366 | 126 | 310.7 | 231.2–417.5 | 40,789 | 140 | 409.3 | 244.7–683.8 | 359.5 | 260.2–496.5 |
65–74 | 21,902 | 134 | 551.1 | 401.6–755.7 | 22,938 | 131 | 555.4 | 410.8–750.5 | 553.2 | 433.9–705.1 |
75–84 | 10,545 | 61 | 490.4 | 333.5–720.4 | 11,655 | 54 | 473.0 | 308.3–724.9 | 480.9 | 350.9–658.9 |
≥85 | 1,768 | 3 | 147.9 | 38.3–569.3 | 2,411 | 7 | 177.7 | 68.2–462.7 | 166.6 | 76.1–364.2 |
Total | 300,192 | 393 | 92.4 | 75.0–113.8 | 296,344 | 436 | 114.7 | 87.2–151.0 | 103.3 | 83.9–127.2 |
Subtotal (≥25) | 216,236 | 393 | 141.7 | 115.1–174.3 | 219,915 | 436 | 170.9 | 128.7–226.9 | 156.2 | 126.0–193.6 |
aA point prevalence in a life time, on 31 August 2013.
bPrevalences and 95% CIs were estimated with complex sample weights.